Viewing StudyNCT00512798



Ignite Creation Date: 2024-05-05 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00512798
Status: TERMINATED
Last Update Posted: 2012-10-02
First Post: 2007-08-06

Brief Title: Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma
Sponsor: Vanderbilt-Ingram Cancer Center
Organization: Vanderbilt-Ingram Cancer Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-06
Start Date Type: None
Primary Completion Date: 2006-07
Primary Completion Date Type: ACTUAL
Completion Date: 2008-03
Completion Date Type: ACTUAL
First Submit Date: 2007-08-06
First Submit QC Date: August 6 2007
Study First Post Date: 2007-08-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2012-08-03
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-09-19
Last Update Post Date: 2012-10-02
Last Update Post Date Type: ESTIMATED